Targeting Inflammation After Myocardial Infarction-Another Piece of the Puzzle

J Cardiovasc Pharmacol. 2022 Jun 1;79(6):769-771. doi: 10.1097/FJC.0000000000001261.

Authors

Daniel I Bromage^{1

2}, Nilesh Pareek^{1

2}, Antonio Cannata^{1

2}, Pietro Ameri^{3

4}

Affiliations

¹ Department of Cardiology, King's College Hospital London, Denmark Hill, Brixton, London, United Kingdom.
² School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, James Black Centre, London, United Kingdom.
³ IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiovascular Network, Genova, Italy; and.
⁴ Department of Internal Medicine, University of Genova, Genova, Italy .

PMID: 35289771
DOI: 10.1097/FJC.0000000000001261

No abstract available

Publication types

Comment

MeSH terms

Humans
Inflammation / drug therapy
Myocardial Infarction*
Myocardium